Instituto Nacional de Saúde, Marracuene, Mozambique.
MassGenics, Assigned to Mozambique Centers for Disease Control and Prevention, Maputo, Mozambique.
Pan Afr Med J. 2022 Apr 14;41:302. doi: 10.11604/pamj.2022.41.302.26979. eCollection 2022.
contact tracing is an important strategy to interrupt the spread of infectious disease and prevent new cases. After the confirmation of the first positive case of COVID-19 in Mozambique on March 22, 2020, case investigation and contact tracing were immediately initiated, which included clinical and laboratory monitoring of cases and contacts throughout the quarantine period. We aim to describe the methodology and impact of early investigation and contact tracing.
in the context of implementation of the national COVID-19 preparedness and response plan, guidelines and forms for contact tracing were adapted from the existing World Health Organization (WHO) and The Centers for Disease Control and Prevention (CDC) guidelines. The case definition used was "patient with travel or residency history in a country reporting local transmission of COVID-19 during the 14 days prior to the onset of symptoms". The cases interviews were face to face and contacts were followed up daily by phone calls for 14 consecutive days: using a structured questionnaire. Data were entered in an electronic Excel database. We collected samples for diagnosis of those who developed symptoms and provided quarantine follow up.
a total of 8 cases were confirmed, of which 6 (75%) were male. The average age of the cases was 51, median 44 (range: 31 to 80) years old. The majority of cases presented common symptoms of COVID-19, including headaches (50%), cough (37.5%), and fever (25%). Our case series included the country´s index case, two close positive contacts, and 5 additional cases that were not epidemiologically linked to the others and identified by the COVID-19 national surveillance system. All of them were identified in Maputo City from March 22 to March 28. Cases had a total of 123 contacts and all of them were tracked; 79 were contacts of the first case. From all the contacts in follow up, two had laboratory confirmed COVID-19. All cases and contacts were quarantined and none of them developed severe symptoms or required hospitalization.
timely case identification and systematic contact tracing can be effective in breaking the chain of COVID-19 transmission when there is strong collaboration between epidemiological, laboratory surveillance and case management.
接触者追踪是阻断传染病传播和预防新发病例的重要策略。2020 年 3 月 22 日,莫桑比克首次确诊 1 例新冠肺炎病例后,立即启动了病例调查和接触者追踪,包括整个隔离期间对病例和接触者进行临床和实验室监测。我们旨在描述早期调查和接触者追踪的方法和影响。
在实施国家新冠肺炎准备和应对计划的背景下,接触者追踪的指南和表格从现有的世界卫生组织(世卫组织)和美国疾病控制与预防中心(CDC)指南中改编而来。使用的病例定义是“在出现症状前 14 天内有旅行或居住史的患者,在该国报告了新冠肺炎的本地传播”。对病例进行面对面访谈,通过电话每天连续 14 天对接触者进行随访:使用结构化问卷。数据输入电子 Excel 数据库。对出现症状的人采集样本进行诊断,并提供隔离后随访。
共确诊 8 例,其中 6 例(75%)为男性。病例的平均年龄为 51 岁,中位数为 44 岁(范围:31-80 岁)。大多数病例表现出新冠肺炎的常见症状,包括头痛(50%)、咳嗽(37.5%)和发热(25%)。本病例系列包括该国的首例病例、2 名密切接触者阳性病例和 5 名其他病例,这些病例与其他病例没有流行病学联系,是通过新冠肺炎国家监测系统发现的。所有这些病例都是在 3 月 22 日至 3 月 28 日期间在马普托市发现的。病例共有 123 名接触者,均已追踪;其中 79 人为首例病例的接触者。在所有接受随访的接触者中,有 2 人经实验室确诊为新冠肺炎。所有病例和接触者均被隔离,无一人出现严重症状或需要住院治疗。
在流行病学、实验室监测和病例管理之间开展强有力的合作时,及时发现病例和系统地追踪接触者可以有效阻断新冠肺炎传播链。